4 reports

HALMRE-## - DRUG PROFILE POLLINEX QUATTRO GRASS - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description Pollinex Quattro Grass Allergy Therapeutics Plc NA GlaxoSmithKline Plc R& D Progress Resea

  • Allergy Drug
  • Eye Disease
  • Ophthalmic Solution
  • Pharmaceutical
  • Product Initiative

The drug candidate activates allergen-specific T-helper type ## (Th##) cellular responses with the production of interferons by antigen presenting cells (APC), natural killer cells (NK), and T cells.

  • Allergy Drug
  • Eye Disease
  • Ophthalmic Solution
  • Pharmaceutical
  • Allergy Therapeutics plc

The drug candidate binds to and inhibits the mRNA of Orai ##, inhibiting the calcium transport.

  • Antifungal
  • Ophthalmic Solution
  • Therapy
  • United States
  • Aldeyra Therapeutics, Inc.

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antifungal
  • Ophthalmic Solution
  • Therapy
  • United States
  • SCYNEXIS, Inc.